Please enable JavaScript to continue using this application.

Compare $ANIK vs $PRTC.L | Chartloom

Compare

$ANIK vs $PRTC.L

ANIK

Anika Therapeutics Inc

PRTC.L

Error

Compare $ANIK vs $PRTC.L

ANIKAnika Therapeutics Inc

PRTC.L

Error

ANIKAnika Therapeutics Inc

Market cap

$262M

P/E (TTM)

—

Forward P/E (NTM)

57.30x

Forward P/S (NTM)

2.09x

Rev growth (TTM)

-2.5%

YTD performance

109.4%

52W performance

111.9%

FCF yield

0.2%

PRTC.L

Market cap

—

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

—

52W performance

—

FCF yield

—

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ANIK

PRTC.L

Not enough overlapping price history for this window.

Detailed metrics comparison

ANIK

Anika Therapeutics Inc

PRTC.L

Market Cap

ANIK$262M

PRTC.L

Enterprise Value

ANIK$224M

PRTC.L

Price

ANIK$19.58

PRTC.L

P/E Ratio

ANIKN/A

PRTC.L

P/S Ratio

ANIK2.17x

PRTC.L

EV/Sales

ANIK1.85x

PRTC.L

EV/EBITDA

ANIK84.97x

PRTC.L

P/B Ratio

ANIK1.86x

PRTC.L

P/FCF Ratio

ANIK466.16x

PRTC.L

EV/FCF

ANIK397.81x

PRTC.L

PEG Ratio

ANIKN/A

PRTC.L

Forward P/E (NTM)

ANIK57.30x

PRTC.L

Forward P/S (NTM)

ANIK2.09x

PRTC.L

Revenue (TTM)

ANIK$121M

PRTC.L

Revenue Growth (YoY)

ANIK-2.5%

PRTC.L

Forward Rev Growth

ANIK5.2%

PRTC.L

Gross Margin (TTM)

ANIK62.2%

PRTC.L

Operating Margin (TTM)

ANIK0.0%

PRTC.L

EBITDA Margin (TTM)

ANIK2.2%

PRTC.L

Net Margin (TTM)

ANIK-3.1%

PRTC.L

FCF Margin (TTM)

ANIK0.5%

PRTC.L

Net Income (TTM)

ANIK$-4M

PRTC.L

FCF (TTM)

ANIK$562K

PRTC.L

EPS (TTM)

ANIK-$0.28

PRTC.L

ROE (TTM)

ANIK-270.0%

PRTC.L

ROA (TTM)

ANIK-204.0%

PRTC.L

ROIC (TTM)

ANIK-270.0%

PRTC.L

Cash

ANIK$38M

PRTC.L

Debt

ANIK$0

PRTC.L

Net Cash/Debt

ANIK$38M

PRTC.L

Current Ratio (TTM)

ANIK4.48x

PRTC.L

Quick Ratio (TTM)

ANIK3.05x

PRTC.L

Debt/Equity (TTM)

ANIK0.00x

PRTC.L

Debt/Assets (TTM)

ANIK0.0%

PRTC.L

Interest Coverage (TTM)

ANIKN/A

PRTC.L

Net Debt/EBITDA (TTM)

ANIK0.00x

PRTC.L

Beta

ANIK0.23

PRTC.L

52W Performance

ANIK111.9%

PRTC.L

YTD Performance

ANIK109.4%

PRTC.L

% from 52W High

ANIK-14.4%

PRTC.L

% from 52W Low

ANIK125.8%

PRTC.L

Asset Turnover (TTM)

ANIK0.65x

PRTC.L

FCF Yield (TTM)

ANIK0.2%

PRTC.L

Earnings Yield (TTM)

ANIK-1.4%

PRTC.L

Dividend Yield (TTM)

ANIKN/A

PRTC.L

Rule of 40

ANIK-2.0

PRTC.L

EV/GP/RG

ANIK0.81

PRTC.L

Ticker research

View ANIK research View PRTC.L research

Metric	ANIK Anika Therapeutics Inc	PRTC.L
Market & Valuation
Market Cap	$262M
Enterprise Value	$224M
Price	$19.58
P/E Ratio	N/A
P/S Ratio	2.17x
EV/Sales	1.85x
EV/EBITDA	84.97x
P/B Ratio	1.86x
P/FCF Ratio	466.16x
EV/FCF	397.81x
PEG Ratio	N/A
Forward P/E (NTM)	57.30x
Forward P/S (NTM)	2.09x
Revenue & Growth
Revenue (TTM)	$121M
Revenue Growth (YoY)	-2.5%
Forward Rev Growth	5.2%
Profitability
Gross Margin (TTM)	62.2%
Operating Margin (TTM)	0.0%
EBITDA Margin (TTM)	2.2%
Net Margin (TTM)	-3.1%
FCF Margin (TTM)	0.5%
Net Income (TTM)	$-4M
FCF (TTM)	$562K
EPS (TTM)	-$0.28
ROE (TTM)	-270.0%
ROA (TTM)	-204.0%
ROIC (TTM)	-270.0%
Financial Health
Cash	$38M
Debt	$0
Net Cash/Debt	$38M
Current Ratio (TTM)	4.48x
Quick Ratio (TTM)	3.05x
Debt/Equity (TTM)	0.00x
Debt/Assets (TTM)	0.0%
Interest Coverage (TTM)	N/A
Net Debt/EBITDA (TTM)	0.00x
Performance
Beta	0.23
52W Performance	111.9%
YTD Performance	109.4%
% from 52W High	-14.4%
% from 52W Low	125.8%
Efficiency & Yields
Asset Turnover (TTM)	0.65x
FCF Yield (TTM)	0.2%
Earnings Yield (TTM)	-1.4%
Dividend Yield (TTM)	N/A
Other
Rule of 40	-2.0
EV/GP/RG	0.81
Ticker research	View ANIK research	View PRTC.L research

Valuation

Growth & revenue

Profitability & performance

Detailed metrics comparison

ANIK

Anika Therapeutics Inc

PRTC.L

Market Cap

ANIK$262M

PRTC.L

Enterprise Value

ANIK$224M

PRTC.L

Price

ANIK$19.58

PRTC.L

P/E Ratio

ANIKN/A

PRTC.L

P/S Ratio

ANIK2.17x

PRTC.L

EV/Sales

ANIK1.85x

PRTC.L

EV/EBITDA

ANIK84.97x

PRTC.L

P/B Ratio

ANIK1.86x

PRTC.L

P/FCF Ratio

ANIK466.16x

PRTC.L

EV/FCF

ANIK397.81x

PRTC.L

PEG Ratio

ANIKN/A

PRTC.L

Forward P/E (NTM)

ANIK57.30x

PRTC.L

Forward P/S (NTM)

ANIK2.09x

PRTC.L

Revenue (TTM)

ANIK$121M

PRTC.L

Revenue Growth (YoY)

ANIK-2.5%

PRTC.L

Forward Rev Growth

ANIK5.2%

PRTC.L

Gross Margin (TTM)

ANIK62.2%

PRTC.L

Operating Margin (TTM)

ANIK0.0%

PRTC.L

EBITDA Margin (TTM)

ANIK2.2%

PRTC.L

Net Margin (TTM)

ANIK-3.1%

PRTC.L

FCF Margin (TTM)

ANIK0.5%

PRTC.L

Net Income (TTM)

ANIK$-4M

PRTC.L

FCF (TTM)

ANIK$562K

PRTC.L

EPS (TTM)

ANIK-$0.28

PRTC.L

ROE (TTM)

ANIK-270.0%

PRTC.L

ROA (TTM)

ANIK-204.0%

PRTC.L

ROIC (TTM)

ANIK-270.0%

PRTC.L

Cash

ANIK$38M

PRTC.L

Debt

ANIK$0

PRTC.L

Net Cash/Debt

ANIK$38M

PRTC.L

Current Ratio (TTM)

ANIK4.48x

PRTC.L

Quick Ratio (TTM)

ANIK3.05x

PRTC.L

Debt/Equity (TTM)

ANIK0.00x

PRTC.L

Debt/Assets (TTM)

ANIK0.0%

PRTC.L

Interest Coverage (TTM)

ANIKN/A

PRTC.L

Net Debt/EBITDA (TTM)

ANIK0.00x

PRTC.L

Beta

ANIK0.23

PRTC.L

52W Performance

ANIK111.9%

PRTC.L

YTD Performance

ANIK109.4%

PRTC.L

% from 52W High

ANIK-14.4%

PRTC.L

% from 52W Low

ANIK125.8%

PRTC.L

Asset Turnover (TTM)

ANIK0.65x

PRTC.L

FCF Yield (TTM)

ANIK0.2%

PRTC.L

Earnings Yield (TTM)

ANIK-1.4%

PRTC.L

Dividend Yield (TTM)

ANIKN/A

PRTC.L

Rule of 40

ANIK-2.0

PRTC.L

EV/GP/RG

ANIK0.81

PRTC.L

Ticker research

View ANIK research View PRTC.L research

Metric	ANIK Anika Therapeutics Inc	PRTC.L
Market & Valuation
Market Cap	$262M
Enterprise Value	$224M
Price	$19.58
P/E Ratio	N/A
P/S Ratio	2.17x
EV/Sales	1.85x
EV/EBITDA	84.97x
P/B Ratio	1.86x
P/FCF Ratio	466.16x
EV/FCF	397.81x
PEG Ratio	N/A
Forward P/E (NTM)	57.30x
Forward P/S (NTM)	2.09x
Revenue & Growth
Revenue (TTM)	$121M
Revenue Growth (YoY)	-2.5%
Forward Rev Growth	5.2%
Profitability
Gross Margin (TTM)	62.2%
Operating Margin (TTM)	0.0%
EBITDA Margin (TTM)	2.2%
Net Margin (TTM)	-3.1%
FCF Margin (TTM)	0.5%
Net Income (TTM)	$-4M
FCF (TTM)	$562K
EPS (TTM)	-$0.28
ROE (TTM)	-270.0%
ROA (TTM)	-204.0%
ROIC (TTM)	-270.0%
Financial Health
Cash	$38M
Debt	$0
Net Cash/Debt	$38M
Current Ratio (TTM)	4.48x
Quick Ratio (TTM)	3.05x
Debt/Equity (TTM)	0.00x
Debt/Assets (TTM)	0.0%
Interest Coverage (TTM)	N/A
Net Debt/EBITDA (TTM)	0.00x
Performance
Beta	0.23
52W Performance	111.9%
YTD Performance	109.4%
% from 52W High	-14.4%
% from 52W Low	125.8%
Efficiency & Yields
Asset Turnover (TTM)	0.65x
FCF Yield (TTM)	0.2%
Earnings Yield (TTM)	-1.4%
Dividend Yield (TTM)	N/A
Other
Rule of 40	-2.0
EV/GP/RG	0.81
Ticker research	View ANIK research	View PRTC.L research